Three- to 4.5-Year Prospective Study of Prognostic Indicators in Gastro-oesophageal Reflux Disease

References

• Richter JE, Castell DO. Gastroesophageal reflux: pathogenesis, diagnosis and therapy. Ann Intern Med 1982;97:93–103.
   PubMed Web of Science ®Google Scholar
• McDougall NI. Diagnosis of reflux disease. Ir J Med Sci 1995; 165:185–90.
   Web of Science ®Google Scholar
• Eriksen CA, Cullen PT, Sutton D, Kennedy N, Cuschieri A. Abnormal esophageal transit in patients with typical reflux symptoms but normal endoscopic and pH profiles. Am J Surg 1991;161:657–61.
   Google Scholar
• Hallerback B, Unge P, Carling L, Edwin B, Glise H, Hava N, et al. Omeprazole or ranitidine in long-term treatment of reflux esophagitis. Gastroenterology 1994;107:1305–11.
   PubMed Web of Science ®Google Scholar
• Dent J, Hetzel DJ, Mackinnon MA, Reed WD, Narielvala FM. Evaluation of omeprazole in reflux oesophagitis. Scand J Gastroenterol 1989;24 Suppl 166:76–82.
   Web of Science ®Google Scholar
• McDougall NI, Johnston BT, Kee F, Collins JSA, McFarland RJ, Love AHG. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996;38:481–6.
   PubMed Web of Science ®Google Scholar
• Klinkenberg-Knol EC, Festen HPM, Jansen JBMJ, Lamers CBHW, Nelis F, Snel F, et al. Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety. Ann Intern Med 1994;121:161–7.
   Google Scholar
• Isolauri J, Luostarinen M, Isolauri E, Reinikainen P, Viljakka M, Keyrilainen O. Natural course of gastroesophageal reflux disease: 17–22 year follow-up of 60 patients. Am J Gastroenterol 1997;92:37–41.
   PubMed Web of Science ®Google Scholar
• Ollyo JB, Monnier P, Fontolliet C, Savary M. The natural history, prevalence and incidence of reflux oesophagitis. Gullet 1993;3 Suppl 1:3–10.
   Google Scholar
• Kuster E, Ros E, Toledo-Pimentel V, Pujol A, Bordas JM, Grande L, et al. Predictive factors of the long term outcome in gastro-oesophageal reflux disease: six year follow-up of 107 patients. Gut 1994;35: 8–14.
   Google Scholar
• Schindlbeck NE, Klauser AG, Berghammer G, Londong W, MullerLissner SA. Three year follow-up of patients with gastroesophageal reflux disease. Gut 1992;33:1016–9.
   Google Scholar
• Pace F, Santalucia F, Bianchi Porro G. Natural history of gastrooesophageal reflux disease without oesophagitis. Gut 1991;32:845–8.
   Google Scholar
• Blum AL, Adami B, Bouzo MH, Brandstatter G, Fumagalli I, Galmiche JP, et al. Effect of cisapride on relapse of esophagitis: a multinational, placebo controlled trial in patients healed with an antisecretory drug. Dig Dis Sci 1993;38:551–60.
   PubMed Web of Science ®Google Scholar
• Poynard T. Relapse rate of patients after healing of oesophagitis—a prospective study of alginate as self-care treatment for 6 months. Aliment Pharmacol Ther 1993;7:385–92.
   PubMed Web of Science ®Google Scholar
• Koelz HR, Birchler R, Bretholz A, Bron B, Capitaine Y, Delmore G, et al. Healing and relapse of reflux esophagitis during treatment with ranitidine. Gastroenterology 1986;91:1198–205.
   PubMed Web of Science ®Google Scholar
• Hetzel DJ, Dent J, Reed WD, Narielvala FM, Mackinnon M, McCarthy JH, et al. Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology 1988;95:903–12.
   PubMed Web of Science ®Google Scholar
• Little AG, De Meester TR, Kirchner PT, O’Sullivan GC, Skinner DB. Pathogenesis of esophagitis in patients with gastroesophageal reflux. Surgery 1980;88:101–7.
   Google Scholar
• Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal TF, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology 1996; 111:85–92.
   PubMed Web of Science ®Google Scholar
• Johnston BT, McFarland RJ, Collins JSA, Love AHG. The symptom index: a useful marker of gastro-oesophageal reflux disease. Br J Surg 1992;79:1054–5.
   PubMed Web of Science ®Google Scholar
• McDougall NI, Johnston BT, Collins JSA, McFarland RJ, Love AHG. Disease progression in gastro-oesophageal reflux disease as determined by repeat oesophageal pH monitoring and endoscopy 3 to 4.5 years after diagnosis. Eur J Gastro Hepatol 1997;9: 1161–7.
   Google Scholar
• Bate CM, Booth SN, Crowe JP, Mountford RA, Keeling PWN, Hepworth-Jones B, et al. Omeprazole 10mg or 20mg once daily in the prevention of recurrence of reflux oesophagitis. Gut 1995;36: 492–8.
   Google Scholar
• Havelund T, Laursen LS, Skoubo-Kristensen E, Andersen BN, Pedersen SA, Jensen KB, et al. Omeprazole and ranitidine in treatment of reflux oesophagitis: double blind comparative trial. Br Med J 1988;296:89–92.
   Google Scholar
• Olden K, Triadafilopoulos G. Failure of initial 24-hour esophageal pH monitoring to predict refractoriness and intractability in reflux esophagitis. Am J Gastroenterol 1991;86:1142–6.
   PubMed Web of Science ®Google Scholar
• Tytgat GNJ, Anker Hansen OJ, Carling L, Geldof H, Glise H. Effect of cisapride on relapse of reflux oesophagitis, healed with an antisecretory drug. Scand J Gastroenterol 1992;27:175–83.
   PubMed Web of Science ®Google Scholar
• Dent J, Yeomans ND, Mackinnon M, Reed W, Narielvala FM, Hetzel DJ, et al. Omeprazole vs ranitidine for prevention of relapse in reflux oesophagitis. A controlled double blind trial of their efficacy and safety. Gut 1994;35:590–8.
   Google Scholar
• Lieberman DA. Medical therapy for chronic reflux esophagitis. Long-term follow-up. Arch Intern Med 1987;147:1717–20.
   PubMedGoogle Scholar
• Norton B, Frazer-Moodie C, Gornall CB, Magnago IS, Weale AR, Holmes GKT. Effect of weight loss on symptoms of gastro- oesophageal reflux. Gut 1995;36 Suppl 1:A29.
   Google Scholar
• Wilson LJ, Hirshowitz BL, Marks Rd, Ma W. Association of obesity with hiatal hernia and oesophagitis. Gastroenterology 1996;110:A296.
   Google Scholar
• Jensen G. Epidemiology of chest pain and angina pectoris. Acta Med Scand 1984;Suppl 682:13–9.
   Google Scholar